Long-term follow-up of a randomized prospective trial comparing a standard 81 mg dose of intravesical bacille Calmette-Guérin with a reduced dose of 27 mg in superficial bladder cancer.
Martínez-Piñeiro JA, Flores N, Isorna S, Solsona E, Sebastián JL, Pertusa C, Rioja LA, Martínez-Piñeiro L, Vela R, Camacho JE, Nogueira JL, Pereira I, Resel L, Muntañola P, Galvis F, Chesa N, De Torres JA, Carballido J, Bernuy C, Arribas S, Madero R; for CUETO (Club Urológico Español de Tratamiento Oncológico).
Martínez-Piñeiro JA, et al. Among authors: galvis f.
BJU Int. 2002 May;89(7):671-80. doi: 10.1046/j.1464-410x.2002.02722.x.
BJU Int. 2002.
PMID: 11966623
Clinical Trial.